Brcatargeting Drugs Could Treat Prostate Cancer Leading Expert Says | Latest News RSS feed

Brcatargeting Drugs Could Treat Prostate Cancer Leading Expert Says - Latest News


BRCA-targeting drugs could treat prostate cancer, leading expert says

A pioneering cancer drug set to become the first to be approved specifically for inherited cancers could also be used much more widely to treat prostate cancer, a world-leading expert said today. Dele... read more

Review of prostate cancer drug Provenge renews medical cost-benefit debate

Although Medicare is not supposed to take cost into consideration when making such rulings, the decision to launch a formal examination has raised concerns among cancer experts, drug companies, lawmak... read more

When Your Partner Has Prostate Cancer

Kababik's parlance is common among partners of men with prostate cancer ... wrong treatment – if there was, all experts would agree on one, Roth points out. In retrospect, "[couples] probably made the ... read more

Looking for another news?


Testicles removal among suitable options for men with advanced prostate cancer —Expert

Any man can have prostate cancer ... may have had treatment that he would never have needed if he had been left alone. If one were to search the community, one would see many people with cancers but t... read more


For new cancer treatments, less is more

"You destroy yourself, and then you can ... drug treatment, a recent study showed. The deescalation trend hasn't spread to all diagnoses. The most common form of thyroid cancer, which poses little ris... read more

Molecular breakthrough could halt the spread of prostate cancer

Explore further: BRCA-targeting drugs could treat prostate cancer, leading expert says More information: 'Serine arginine protein kinase-1 (SRPK1) inhibition as a potential novel targeted therapeutic ... read more

Getting Tested for Prostate Cancer May Be Worth It After All

TIME Health Newsletter Get the latest health and science news, plus: burning questions and expert tips ... deaths from prostate cancer, as the U.S. and European studies did, but on the financial and h... read more

Drug Prices In Ads Could Cause Sticker Shock For Consumers, Forcing Pharma To Tinker With Marketing Strategies

Experts don't predict ... Novartis To Buy Cancer-Drug Maker Endocyte For $2.1 Billion Novartis AG on Thursday said it would pay $2.1 billion for Endocyte Inc., a U.S. company developing a new treatmen... read more

Study Discounts Testosterone Therapy for Early Prostate Cancer

Androgen deprivation can help improve survival in these patients when combined with radiation or other treatments. But experts have become increasingly concerned about the widespread use of this treat... read more

Cancer Fatigue: So Tired by Treatment

He didn't require chemotherapy but received a drug called Lupron, used to treat prostate cancer. "Suddenly, in late December, I started to feel the fatigue," Perkins says ... can affect patients, some... read more

New Diagnostic Tools for Prostate Cancer

Dan Woska was weighing his treatment ... Myriad’s Prolaris prostate cancer biomarker test, saying it had not been studied adequately for clinical use and could lead to overtreatment or undertreatment ... read more

Review of prostate cancer drug Provenge renews medical cost-benefit debate

Federal officials are conducting an unusual review to determine whether the government should pay for an expensive new vaccine for treating prostate ... has raised concerns among cancer experts, drug ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us